ReWalk Robotics Applauds Medicare Proposal to Include Personal Exoskeletons in a Medicare Benefit Category to be Paid on a Lump Sum Basis[...]
Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use on Stairs and Curbs Paralyzed individuals with spinal[...]
The ReBoot is a lightweight, battery-powered orthotic exo-suit intended to assist ambulatory functions in individuals with reduced ankle function related to neurological[...]
Experts outline potential for improved stroke patient outcomes, cost-effectiveness through use of the ReStore device in the rehabilitation setting MARLBOROUGH, Mass., March 3,[...]
This supply contract is the first between ReWalk and a German company health insurance fund MARLBOROUGH, Mass. and BERLIN, March 2, 2021 /PRNewswire/ — ReWalk Robotics, Ltd. (Nasdaq:[...]
Covid-19 Pandemic Has Further Illustrated Need for Innovative Stroke Rehab Solutions MARLBOROUGH, Mass., Dec. 21, 2020 /PRNewswire/ — ReWalk Robotics, Ltd. (Nasdaq:[...]
Supply contract is the Company’s first with a private health insurer in Germany MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Dec. 10, 2020 (GLOBE NEWSWIRE) — ReWalk Robotics, Ltd. (Nasdaq:[...]
Ms. Richner is an experienced public health policy professional with over 30 years of experience in Medical Devices, Reimbursement Strategy and Health Care[...]
First of Its Kind HCPCS Level II Code is a Breakthrough for Access to Exoskeletons for Individuals with Spinal Cord Injury Company[...]
